Regenxbio (RGNX) Debt Ratio (2014)

Regenxbio (RGNX) recorded quarterly Debt Ratio of 0.41 in Q4 2014.

Regenxbio (RGNX) Debt Ratio (2014) Analysis & Trends

Regenxbio's Debt Ratio history runs 1 years deep, the most recent figure standing at 0.41 for Q4 2014.

In Q4 2014, Debt Ratio changed N/A year-over-year to 0.41; the TTM figure through Dec 2014 stood at 0.41 (changed N/A YoY), while the FY2014 annual figure was 0.41, changed N/A from the prior year.
Debt Ratio was 0.41 for Q4 2014 at Regenxbio.
In the past five years, Debt Ratio ranged from a high of 0.41 in Q4 2014 to a low of 0.41 in Q4 2014.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	0.18
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Regenxbio	315.11 Mn	85.04 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2014	0.41